Clinicians may also advise timing medication relative to mealstaking injections at a consistent time and aligning meals to predictable patterns helps stabilize GI response
Weight Loss Potential : The GLP-1 Protocol typically leads to up to 15% body weight reduction, while the Advanced GLP-1 Protocol leads to up to 20-22% body weight reduction, offering enhanced results for some patients
Many patients experience improvement in side effects, including lightheadedness, after the initial adjustment period of 4-8 weeks
Saxenda is a prescription medication
Mounjaro contains tirzepatide, which is known for GLP-1 and GIP receptor activity
For the double composite endpoint, cost of control was lower with oral semaglutide 14 mg by USD 525, 32,277 and 13,011, respectively versus empagliflozin 25 mg, sitagliptin 100 mg and liraglutide 1.8 mg